Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women

被引:0
|
作者
Teede, HJ
Dalais, FS
McGrath, BP
机构
[1] Monash Univ, Dept Med, Vasc Res Grp, Clayton, Vic 3168, Australia
[2] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia
来源
关键词
genistein; daidzein; lipids; estrogenic effects; gonadotropins;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Dietary phytoestrogens are ligands for the estrogen receptor and may mimic estrogenic effects in vivo. Objective: To assess the biological activity of isoflavone phytoestrogens, we analyzed the effect of dietary soy isoflavone supplementation on in vivo bioassays of estrogenicity. Design: Fifty healthy postmenopausal women aged 50-75 y participated in a double-blind, placebo-controlled trial in which they received either soy protein isolate (40 g soy protein, 118 mg isoflavones) or casein placebo. Measurements were made at baseline and at 3 mo. Urinary isoflavone excretion was measured to reflect compliance. The bioassays of estrogenicity included measurement of hepatic proteins and gonadotropin concentrations. Results: Baseline characteristics were not significantly different between the soy and placebo groups. Urinary isoflavone excretion increased in the soy group and at the end of 3 mo was higher in the soy group than in the placebo group. In plasma samples from both groups, C-reactive protein increased significantly over the 3-mo treatment period, whereas sex hormone-binding globulin and thyroid-binding globulin decreased significantly. However, there were no significant differences between the groups in hepatic protein synthesis (change over 3 mo +/- SEM in the soy and placebo groups, respectively): C-reactive protein, 0.42 +/- 0.2 and 0.48 +/- 0.2 U/mL; sex hormone-binding globulin, -6.9 +/- 1.5 and -10.0 +/- 2.1 mug/mL; thyroid-binding globulin, -16 +/- 8 and -26 +/- 7 nmol/L. Furthermore, gonadotropin and dehydroepiandrosterone sulfate concentrations did not change significantly in either group. Conclusions: In healthy postmenopausal women, dietary soy isoflavones do not affect in vivo biological indicators of estrogenicity, including hepatic protein synthesis and gonadotropin concentrations. 4 This suggests that soy isoflavones have little biologically relevant estrogenic effect in vivo in postmenopausal women.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 50 条
  • [21] Dietary equol does not reproduce effects of dietary soy on cardiovascular disease risk variables; Observations from postmenopausal monkeys
    Appt, SE
    Clarkson, TB
    Register, TC
    Chen, H
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 784 - 784
  • [22] Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study
    Burke, GL
    Legault, C
    Anthony, M
    Bland, DR
    Morgan, TM
    Naughton, MJ
    Leggett, K
    Washburn, SA
    Vitolins, MZ
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (02): : 147 - 153
  • [23] Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women
    Maesta, Nailza
    Nahas, Eliana A. P.
    Nahas-Neto, Jorge
    Orsatti, Fabio L.
    Fernandes, Cesar E.
    Traiman, Paulo
    Burini, Roberto C.
    MATURITAS, 2007, 56 (04) : 350 - 358
  • [24] Possible beneficial effects of soy protein on the vascular endothelium in postmenopausal women - Future directions
    Blum, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (01): : 56 - 58
  • [25] Design and baseline characteristics of a trial on health effects of soy protein with isoflavones in postmenopausal women
    Kok, L
    Kreijkamp-Kaspers, S
    Grobbee, DE
    van der Schouw, YT
    MATURITAS, 2004, 47 (01) : 21 - 29
  • [26] Long term effects of soy protein and isoflavones on plasma lipid profiles in postmenopausal women
    Baum, J
    Erdman, JW
    Klein, BP
    Freels, S
    Persky, V
    Bakhit, RM
    Potter, SM
    FASEB JOURNAL, 1996, 10 (03): : 2929 - 2929
  • [27] Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women
    Greany, K. A.
    Nettleton, J. A.
    Wangen, K. E.
    Thomas, W.
    Kurzer, M. S.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2008, 62 (12) : 1419 - 1425
  • [28] Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women
    K A Greany
    J A Nettleton
    K E Wangen
    W Thomas
    M S Kurzer
    European Journal of Clinical Nutrition, 2008, 62 : 1419 - 1425
  • [29] Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: The soy estrogen alternative study.
    Burke, GL
    Legault, C
    Anthony, M
    Bland, DR
    Morgan, TM
    Naughton, MJ
    Harris, K
    Washburn, SA
    Vitolins, MZ
    JOURNAL OF NUTRITION, 2002, 132 (03): : 600S - 600S
  • [30] Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women
    Evans, Ellen M.
    Racette, Susan B.
    Van Pelt, Rachael E.
    Peterson, Linda R.
    Villareal, Dennis T.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (03): : 481 - 488